These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 32917240)

  • 1. Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab.
    Li J; Ma M; Yang X; Zhang M; Luo J; Zhou H; Huang N; Xiao F; Lai B; Lv W; Zhang N
    Mol Cancer; 2020 Sep; 19(1):142. PubMed ID: 32917240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circ-ZEB1 acts as an oncogene in triple negative breast cancer via sponging miR-448.
    Pei X; Zhang Y; Wang X; Xue B; Sun M; Li H
    Int J Biochem Cell Biol; 2020 Sep; 126():105798. PubMed ID: 32629026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circ-ERBB2 Elevates the Warburg Effect and Facilitates Triple-Negative Breast Cancer Growth by the MicroRNA 136-5p/Pyruvate Dehydrogenase Kinase 4 Axis.
    Huang Y; Zheng S; Lin Y; Ke L
    Mol Cell Biol; 2021 Sep; 41(10):e0060920. PubMed ID: 34370552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ-TFCP2L1 Promotes the Proliferation and Migration of Triple Negative Breast Cancer through Sponging miR-7 by Inhibiting PAK1.
    Wang Q; Li Z; Hu Y; Zheng W; Tang W; Zhai C; Gu Z; Tao J; Wang H
    J Mammary Gland Biol Neoplasia; 2019 Dec; 24(4):323-331. PubMed ID: 31776835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.
    Li H; Xu W; Xia Z; Liu W; Pan G; Ding J; Li J; Wang J; Xie X; Jiang D
    Aging (Albany NY); 2021 Jan; 13(3):4522-4551. PubMed ID: 33495420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis.
    Xing L; Yang R; Wang X; Zheng X; Yang X; Zhang L; Jiang R; Ren G; Chen J
    Aging (Albany NY); 2020 Jun; 12(11):10983-11003. PubMed ID: 32497020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway.
    Wang L; Zhou Y; Jiang L; Lu L; Dai T; Li A; Chen Y; Zhang L
    Mol Cancer; 2021 Mar; 20(1):43. PubMed ID: 33648498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Circ_0000977-Mediated Regulatory Network in Breast Cancer: A Potential Discriminative Biomarker for Triple-Negative Tumors.
    Darbeheshti F; Mansoori Y; Azizi-Tabesh G; Zolfaghari F; Kadkhoda S; Rasti A; Rezaei N; Shakoori A
    Biochem Genet; 2023 Aug; 61(4):1487-1508. PubMed ID: 36645554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ-TRIO promotes TNBC progression by regulating the miR-432-5p/CCDC58 axis.
    Wang Z; Li Y; Yang J; Liang Y; Wang X; Zhang N; Kong X; Chen B; Wang L; Zhao W; Yang Q
    Cell Death Dis; 2022 Sep; 13(9):776. PubMed ID: 36075896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. circUSP42 Is Downregulated in Triple-Negative Breast Cancer and Associated With Poor Prognosis.
    Yu J; Shen W; Xu J; Gong B; Gao B; Zhu J
    Technol Cancer Res Treat; 2020; 19():1533033820950827. PubMed ID: 32938310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.
    Wang X; Chen T; Li C; Li W; Zhou X; Li Y; Luo D; Zhang N; Chen B; Wang L; Zhao W; Fu S; Yang Q
    J Hematol Oncol; 2022 Aug; 15(1):122. PubMed ID: 36038948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/KRAS and IGF2BP2/Myc axes.
    Li J; Gao X; Zhang Z; Lai Y; Lin X; Lin B; Ma M; Liang X; Li X; Lv W; Lin Y; Zhang N
    Mol Cancer; 2021 Oct; 20(1):138. PubMed ID: 34696797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a.
    He R; Liu P; Xie X; Zhou Y; Liao Q; Xiong W; Li X; Li G; Zeng Z; Tang H
    J Exp Clin Cancer Res; 2017 Oct; 36(1):145. PubMed ID: 29037220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway.
    Wang ST; Liu LB; Li XM; Wang YF; Xie PJ; Li Q; Wang R; Wei Q; Kang YH; Meng R; Feng XH
    Neoplasma; 2019 Mar; 66(2):232-239. PubMed ID: 30509108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression.
    Zou Y; Zheng S; Xiao W; Xie X; Yang A; Gao G; Xiong Z; Xue Z; Tang H; Xie X
    Carcinogenesis; 2019 Dec; 40(12):1469-1479. PubMed ID: 31001629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1.
    Xiao W; Zheng S; Zou Y; Yang A; Xie X; Tang H; Xie X
    Aging (Albany NY); 2019 Dec; 11(24):12043-12056. PubMed ID: 31857500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA-associated ceRNA network involved in HIF-1 signalling in triple-negative breast cancer: circ_0047303 as a potential key regulator.
    Darbeheshti F; Mahdiannasser M; Noroozi Z; Firoozi Z; Mansoori B; Daraei A; Bastami M; Nariman-Saleh-Fam Z; Valipour E; Mansoori Y
    J Cell Mol Med; 2021 Dec; 25(24):11322-11332. PubMed ID: 34791795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs.
    Reddy TP; Choi DS; Anselme AC; Qian W; Chen W; Lantto J; Horak ID; Kragh M; Chang JC; Rosato RR
    Breast Cancer Res; 2020 May; 22(1):48. PubMed ID: 32414394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of circ-UBAP2 predicts poor prognosis and promotes triple-negative breast cancer progression through the miR-661/MTA1 pathway.
    Wang S; Li Q; Wang Y; Li X; Wang R; Kang Y; Xue X; Meng R; Wei Q; Feng X
    Biochem Biophys Res Commun; 2018 Nov; 505(4):996-1002. PubMed ID: 30314706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.